Understand the source comparison
Peptide Deals November 2026: Quality vs Price Analysis
GLP-1 Agonists (Semaglutide, Tirzepatide) 20–30% 3–6 months Moderate (high demand = fast turnover) Strong value if COA confirms purity ≥98% and synthesis <6 months Growth Hormone Secretagogues (MK-677, CJC/Ipa) 25–35% 4–8 months High (shipping volume peaks in
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- GLP-1 Agonists (Semaglutide, Tirzepatide)
- 20–30%
- 3–6 months
- Moderate (high demand = fast turnover)
- Strong value if COA confirms purity ≥98% and synthesis <6 months
- Growth Hormone Secretagogues (MK-677, CJC/Ipa)
- 25–35%
- 4–8 months
- High (shipping volume peaks in November)
- Verify cold-chain shipping. 35% discount negated by one temperature excursion
- Nootropic Peptides (Cerebrolysin, Dihexa, P21)
- 15–25%
- 2–5 months
- Low (lower order volume = less shipping strain)
- Safest category for November deals. Lower risk of logistics failures
- Metabolic Research Compounds (Tesofensine, Survodutide)
- 30–40%
- 6–10 months
- Very High (limited suppliers = less shipping infrastructure)
- High value if supplier provides synthesis date + HPLC. Avoid if no documentation